Turkey rhinotraeheitis (TRT) virus is a paramyxovirus associated with recent outbreaks of acute respiratory disease in turkeys. On morphological criteria it resembles the pneumoviruses more than the other members of the paramyxovirus family. In this communication we report the identification of five virus-induced polypeptides in TRT virus-infected BS-C-1 ceils. The M r of these polypeptides were estimated as 38K, 35K, 30K, 19K and 15K from their electrophoretic mobility in SDSpolyacrylamide 6 to 15 ~ gradient gels. The virus specificity of four (the 38K, 35K, 30K and 19K Mr polypeptides) of these five was confirmed by their predominance as products of in vitro translation of mRNA from TRT virus-infected BS-C-1 cells. An additional virus-specific polypeptide with an estimated Mr of 22K was revealed by in vitro translation and may be either a non-structural polypeptide or a minor structural protein. All six polypeptides were immunoprecipitated by a murine antiserum. Three other polypeptides (129K, 57K and 45K) were also immunoprecipitated. The 57K, 45K and 15K Mr polypeptides were glycosylated, and the 57K glycopolypeptide may be a disulphide-bonded dimer of the 45K and 15K glycopolypeptides. Another major glycopolypeptide of 83K Mr was observed but its virus-specificity could not be confirmed. Taken together our results tentatively identify eight or nine TRT virusspecified polypeptides and are consistent with the classification of TRT virus as a new member of the genus Pneumovirus.
Turkey rhinotraeheitis (TRT) virus is a paramyxovirus associated with recent outbreaks of acute respiratory disease in turkeys. On morphological criteria it resembles the pneumoviruses more than the other members of the paramyxovirus family. In this communication we report the identification of five virus-induced polypeptides in TRT virus-infected BS-C-1 ceils. The M r of these polypeptides were estimated as 38K, 35K, 30K, 19K and 15K from their electrophoretic mobility in SDSpolyacrylamide 6 to 15 ~ gradient gels. The virus specificity of four (the 38K, 35K, 30K and 19K Mr polypeptides) of these five was confirmed by their predominance as products of in vitro translation of mRNA from TRT virus-infected BS-C-1 cells. An additional virus-specific polypeptide with an estimated Mr of 22K was revealed by in vitro translation and may be either a non-structural polypeptide or a minor structural protein. All six polypeptides were immunoprecipitated by a murine antiserum. Three other polypeptides (129K, 57K and 45K) were also immunoprecipitated. The 57K, 45K and 15K Mr polypeptides were glycosylated, and the 57K glycopolypeptide may be a disulphide-bonded dimer of the 45K and 15K glycopolypeptides. Another major glycopolypeptide of 83K Mr was observed but its virus-specificity could not be confirmed. Taken together our results tentatively identify eight or nine TRT virusspecified polypeptides and are consistent with the classification of TRT virus as a new member of the genus Pneumovirus.
A virus associated with outbreaks of acute upper respiratory tract disease in turkeys in the U.K. since 1985 may be a previously unrecognized pneumovirus (Wyeth et al., 1986; Collins et al., 1986) . In the accompanying communication Collins & Gough (1988) present evidence, from electron microscopy and Coomassie Brilliant Blue (CBB) staining of SDS-polyacrylamide gels of partially purified virion proteins, that supports the classification of this virus, now designated turkey rhinotracheitis (TRT) virus, as a member of the genus Pneumovirus of the family Paramyxoviridae. In this report we present the results of analysis of protein synthesis in TRT virus-infected cells, in vitro translation of mRNA from TRT virus-infected cells, immunoprecipitation and cross-neutralization experiments, which are consistent with the classification of TRT virus as a pneumovirus.
An isolate of the CVL 14/1 strain of TRT virus propagated in chick embryo fibroblast cells was supplied by the Central Veterinary Laboratory (Weybridge, U.K.) and inoculated onto a monolayer culture of BS-C-1 cells. After several cycles of replication in BS-C-1 cells, two distinct types of cytopathic effect were observed. Dilutions of this passaged material were plated out under 0.9~ agar-containing overlay and after 5 days incubation at 33 °C two extreme plaque phenotypes were observed. The major plaque type was visible as aggregates of darkly stained cells after glutaraldehyde fixation and crystal violet staining (Fig. 1 a) . These plaques resembled the focal type of plaque characteristic of the pneumoviruses respiratory syncytial (RS) virus (Faulkner et al., 1976) and pneumonia virus of mice (PVM) (Cash et al., 1979) in BS-C-1 cells. Also present were large syncytial plaques (Fig. 1 b) . The plaque morphology phenotype was not dependent on cell type, since both focal and syncytial plaques were also observed on monolayers of MRC-5 cells. Stocks of each plaque type were established by six sequential reisolations from individual plaques. In order to establish whether these plaque types represented variants of the same virus or two unrelated viruses, mice (BALB/c strain) were inoculated with each virus to obtain specific antisera. The mice received two inoculations, 10 days apart, of material released into the supernatant of cultures of 4 x 106 TRT virus-infected BS-C-1 cells incubated at 33 °C until cytopathic effect was extensive. This material was concentrated before inoculation by precipitation with 6~ polyethylene glycol (6000 Mr; BDH) and resuspended in 0.2ml phosphate-buffered saline (PBS). The concentrated supernatant was mixed with an equal volume of Freund's complete adjuvant for the first injection and Freund's incomplete adjuvant for the second injection. The animals were bled 10 days after the second inoculation. The serum was separated and before use adsorbed overnight with 10~ (w/v) acetone-fixed uninfected BS-C-1 cells. The antisera to the two viruses neutralized infectivity in homologous and heterologous combinations, but the focal plaque-forming (FP) virus was neutralized to a greater extent than the syncytial plaque-forming (SP) virus (Table 1) .
These results confirm that the two plaque types represent variants of the same virus rather than two different viruses. The FP variant and the SP variant exhibited similar growth rates in single-cycle infections (data not shown), but the FP variant was employed in all of the following experiments because it grew consistently to higher titres and was less susceptible to loss of titre on storage at -7 0 °C. Particles similar to those described by Collins & Gough (1988) were observed in electron micrographs of negatively stained material concentrated from culture supernatant (data not shown). * The convalescent and hyperimmune chicken and turkey sera were obtained from the Poultry Department of the Cemral Veterinary Laboratory (Weybridge, U.K.), the normal chicken and turkey sera from Sera-Lab (Crawley Down, U.K.), the anti-RS virus serum from Dr E. J. Stott (AFRC Institute, Compton, U.K.) and the anti-PVM serum was the hyperimmune mouse serum described in the text.
1" Reciprocal of the 50~ endpoint. :~ ND, Not determined.
The mouse antisera to the two variants of TRT virus did not cross-neutralize representatives of either of the other two recognized members of the pneumovirus genus, RS virus (strain RSS-2) and PVM (strain 15). Likewise murine anti-PVM and bovine anti-RS virus sera did not neutralize the infectivity of either variant of TRT virus. However, convalescent sera from TRT virus-infected turkeys and chickens did neutralize the injectivity of PVM, whereas the sera of uninfected turkeys or chickens had no comparable activity. The significance of these results is unclear since the neutralizing activity of these same sera against either variant of TRT virus was not high (Table 2) . None of the turkey or chicken sera had any discernible neutralizing activity against RS virus.
Collins & Gough (1988) have identified seven presumptive structural polypeptides in CBBstained SDS-polyacrylamide gels of extracts of partially purified TRT virus. These have been designated by Collins & Gough according to their estimated Mr as 200K, 84K, 54K, 42K, 37K, 31K and 14K. The 84K and 54K polypeptides were considered to be glycoproteins on the basis of their reaction with Schiff's reagent; the 84K protein was detected by Schiff's staining only and not by CBB staining.
In this communication we report the detection of six virus-specific polypeptides in TRT virusinfected BS-C-1 cells radiolabelled with [35S]methionine, four of which correspond by Mr with the 42K, 37K, 31K and 14K structural polypeptides identified by Collins & Gough (1988) . An additional polypeptide with an estimated Mr of 19K was detected in virus-infected cells and may be a virus-specified non-structural polypeptide. The virus specificity of four of these five polypeptides was confirmed by comparison of the results of in vitro translation of mRNA from uninfected and TRT virus-infected BS-C-I cells. One other virus-specific polypeptide with an estimated Mr of 22K was revealed by in vitro translation and may be either a non-structural polypeptide or a minor structural protein. Our results taken together with the data of Collins & Gough (1988) tentatively identify nine TRT virus-specified polypeptides.
To detect synthesis of TRT virus polypeptides intracellularly, monolayers of 106 BS-C-1 cells were infected with a 4 x 106 p.f.u, of TRT virus, and after adsorption for 2 h at 33 °C the inoculum was replaced with Eagle's medium (Glasgow modification) supplemented with 1 foetal calf serum plus antibiotics. Forty-eight h after inoculation this medium was replaced by methionine-free Eagle's medium containing 2.5 ~tg/ml actinomycin D and the cells were incubated for 3 h at 33 °C prior to incubation for a further 24 h in the same medium containing 50 BCi/ml [3SS]methionine (Amersham). The supernatants were then discarded and the cells scraped into PBS containing 1 mM-PMSF, pelleted and washed in the same buffer, then resuspended in 40 ~tl SDS sample buffer (Laemmli, 1970) . The polypeptides were analysed by electrophoresis in 6 to 15~o acrylamide gradient gels (Marsden et al., 1976) followed by fluorography using Amplify (Amersham). Fig. 2(a) and are not present in the extract of mock-infected cells. The Mr estimates were obtained by comparison with a range of marker proteins (see legend to Fig. 2 ) run in parallel in the same gel. The 84K and 54K glycopolypeptides identified by Collins & Gough (1988) were not detected in these experiments, perhaps indicative of a low content of methionine such as is characteristic of one of the two envelope proteins of RS virus (Wertz et al., 1985) . The 38K, 35K, 30K and 15K Mr polypeptides probably correspond to the structural polypeptides designated 42K, 37K, 31K and 14K by Collins & Gough (1988) . The difference in Mr estimates is due to the different gel conditions and the different range of reference marker proteins employed. The mobility of these polypeptides relative to those of RS virus and PVM, however, is the same in each case [compare Fig. 2b with Fig. 2 of Collins & Gough (1988) ]. The 19K Mr polypeptide was not detected by Collins & Gough and may represent a non-structural protein.
The 38K, 35K, 30K and 19K Mr polypeptides were also detected as products of in vitro translation of mRNA extracted from TRT virus-infected BS-C-1 cells at 72 h p.i. (Fig. 2b) . Monolayers of 4 × 107 BS-C-1 cells were infected with either 0,5 p.f.u./cell TRT virus, 2 p.f.u./cell RS virus, 1 p.f.u./cell PVM, or mock-infected. Two h after addition of the virus, the inoculum was replaced by Eagle's medium (Glasgow modification) supplemented with 1 ~o foetal calf serum and incubated for a further 24 h at 37 °C. This medium was replaced by fresh medium containing 2.5 ~tg/ml actinomycin D and incubated at 37 °C for a further 24 h in the case of RS virus-and PVM-infected cells and 48 h in the case of TRT virus-infected and mockinfected cells. The cells were then lysed on ice with 5 ml isotonic lysis buffer (150 m~-NaC1, 1.5 mM-MgClz, 0.65~ Nonidet P40, 10 mM-Tris-HC1 pH 7.8) and added together with phenol extraction buffer (7 u-urea, 350 mM-NaC1, 10 mM-EDTA, 1 ~ SDS, 10 mM-Tris-HC1 pH 7.8) to 5 ml phenol/chloroform (equilibrated with 150 mM-NaC1, 1 mM-EDTA, I0 mM-Tris-HC1 pH 7.8). The aqueous phase was extracted twice with phenol/chloroform and precipitated with 3 volumes of ethanol at -20 °C overnight. The precipitate was pelleted by centrifugation at 4000 g for 25 rain at 4 °C and after drying resuspended at 1 mg/ml in diethyl pyrocarbonate ( The virus specificity of all six polypeptides detected by in vivo and in vitro radiolabelling has been confirmed by immunoprecipitation by specific antiserum. The convalescent avian anti-TRT virus sera available to us have moderate neutralization titres and did not immunoprecipitate well even in the homologous combination. On the other hand the murine anti-TRT virus serum described above was effective, although of low neutralizing titre. BS-C-1 cells were infected with TRT virus or mock-infected and radiolabelled using [3SS]methionine as described above. The cells were lysed on ice using 2~ Nonidet P40 in 100 ~tl PBS containing 1 mM-PMSF for 30rain. The lysate was clarified by centrifugation at 10000g for 5min and 50~tl Immunoprecipitin (Gibco-Bethesda Research Laboratories) in RIP buffer (0.15 M-NaC1, 1 Triton X-100, 1~o sodium deoxycholate, 0.1~ SDS, 10mM-Tris-HC1 pH7.4) and 5~tl preimmune mouse serum was added. The lysates were incubated a further 30 min on ice, the Immunoprecipitin pelleted for 5 min at 10000 g and the supernatant incubated overnight at 4 °C with 50 ~tl mouse anti-TRT virus serum. Then 300 Ixl of Immunoprecipitin in RIP buffer was added and after 30 min on ice the precipitate was washed in 500 mM-lithium chloride, 100 mMTris-HC1 pH 8.5 by three cycles of resuspension and centrifugation at 10000g for 1 min. The washed pellet was resuspended in 40 ~tl SDS lysis buffer and boiled for 3 min, pelleted for 1 min at 10000g and the supernatant loaded onto a 6 to 15~ gradient gel and electrophoresed at 12 mA overnight. Fig. 2(c) shows that the 38K, 35K, 30K, 22K, 19K and 15K polypeptides identified in the in vivo and in vitro radiolabelling experiments were precipitated by the anti-TRT virus serum, confirming their virus specificity.
Three other polypeptides of Mr 129K, 57K and 45K were also precipitated by the mouse anti-TRT virus serum (Fig. 2c) . The virus specificity of the 129K polypeptide is unclear, however, because material of similar Mr was precipitated from mock-infected cells. The 45K and 15K polypeptides were also observed, however, when supernatants from TRT virus-infected cells labelled with [3H]glucosamine hydrochloride (Amersham) were precipitated with 6~o polyethylene glycol and then immunoprecipitated as above (Fig. 3a) . The same samples run under non-reducing conditions revealed a 57K polypeptide with a concomitant reduction in the labelling of the 45K and 15K polypeptides (Fig. 3b) . These experiments suggest that the 57K glycoprotein may be a disulphide-bonded dimer of the 45K and 15K polypeptides, analogous to the F (fusion) protein of RS virus. The 57K dimer or the 45K monomer form may correspond to the 54K structural glycoprotein described by Collins & Gough (1988) . Further work is required to define the glycoproteins of TRT virus.
